The company's strong relationship with Cipla has been key in allowing the company to continuously increase its market share through the launch of a number of new molecules and establishing a solid reputation for swift launches and championing affordable healthcare Headquartered in Cape Town, with regional offices throughout the country, Cipla is listed on the Johannesburg Securities Exchange through holding company Cipla Medpro South Africa Limited